Management of contemporary early undifferentiated arthritis: data on EULAR's recommendation on the risk of persistent disease

Ann Rheum Dis. 2022 May;81(5):740-741. doi: 10.1136/annrheumdis-2021-221821. Epub 2022 Jan 27.
No abstract available

Keywords: anti-citrullinated protein antibodies; arthritis; autoantibodies; rheumatoid; rheumatoid factor.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arthritis* / diagnosis
  • Arthritis* / drug therapy
  • Autoantibodies
  • Humans
  • Peptides, Cyclic
  • Rheumatoid Factor*

Substances

  • Autoantibodies
  • Peptides, Cyclic
  • Rheumatoid Factor